Simple jQuery Dropdowns
Please use this identifier to cite or link to this item: http://repository.li.mahidol.ac.th/dspace/handle/123456789/41850
Title: Prevalence and predictors of cardiac and liver iron overload in patients with thalassemia: A multicenter study based on real-world data
Authors: Rungroj Krittayaphong
Vip Viprakasit
Pairash Saiviroonporn
Noppadol Siritanaratkul
Suvipaporn Siripornpitak
Arunotai Meekaewkunchorn
Thawatchai Kirawittaya
Pornpun Sripornsawan
Arunee Jetsrisuparb
Jiraporn Srinakarin
Peerapon Wong
Nuttaporntira Phalakornkul
Phakatip Sinlapamongkolkul
John Wood
Mahidol University
Queen Sirikit National Institute of Child Health
Prince of Songkla University
Khon Kaen University
Naresuan University
Bhumibol Adulyadej Hospital
Faculty of Medicine, Thammasat University
Children's Hospital Los Angeles
Keywords: Biochemistry, Genetics and Molecular Biology
Issue Date: 1-Jul-2017
Citation: Blood Cells, Molecules, and Diseases. Vol.66, (2017), 24-30
Abstract: © 2017 Elsevier Inc. Prevalence of cardiac and liver iron overload in patients with thalassemia in real-world practice may vary among different regions especially in the era of widely-used iron chelation therapy. The aim of this study was to determine the prevalence of cardiac and liver iron overload in and the management patterns of patients with thalassemia in real-world practice in Thailand. We established a multicenter registry for patients with thalassemia who underwent magnetic resonance imaging (MRI) as part of their clinical evaluation. All enrolled patients underwent cardiac and liver MRI for assessment of iron overload. There were a total of 405 patients enrolled in this study. The mean age of patients was 18.8 ± 12.5 years and 46.7% were male. Two hundred ninety-six (73.1%) of patients received regular blood transfusion. Prevalence of cardiac iron overload (CIO) and liver iron overload (LIO) was 5.2% and 56.8%, respectively. Independent predictors for iron overload from laboratory information were serum ferritin and transaminase for both CIO and LIO. Serum ferritin can be used as a screening tool to rule-out CIO and to diagnose LIO. Iron chelation therapy was given in 74.6%; 15.3% as a combination therapy.
URI: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85028939540&origin=inward
http://repository.li.mahidol.ac.th/dspace/handle/123456789/41850
ISSN: 10960961
10799796
Appears in Collections:Scopus 2016-2017

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.